Supreme Petrochem Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹1,957 Cr +77.9% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
SP

Supreme Petrochem Ltd

Q4 FY26Chemicals & Petrochemicals

Supreme Petrochem Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹1,587Cr
+3.1% YoY
+25.5% QoQ
Net profit
₹168Cr
+57% YoY
+460% QoQ
Margin
16%
+7 pp YoY
+11 pp QoQ
Price₹698
Market cap₹13.3K Cr
P/E27.1

The short version

The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026. The company anticipates volume growth of 8-10% for the year if global conditions, including war impacts, normalize by June-July 2026.

From Supreme Petrochem Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026.
  • With ABS operational, overall volume growth aligns with market growth; however, Q1 FY27 might see lower growth due to ongoing global uncertainties.
  • The ABS plant currently operates at around 65-70% capacity with expectations to reach 80-90% utilization in FY27.
  • Phase two expansion of ABS is underway, independent of equipment issues, indicating future capacity increase.
  • The EPS Phase-II expansion was successfully commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum.

2 more points from Supreme Petrochem Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Supreme Petrochem Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • EPS Phase-II expansion at Nagothane commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum.
  • ABS mass plant restarted with modified arrangements, currently operating at ~65% capacity; aiming to reach 80-90% utilization in FY27.
  • Phase-II ABS expansion planned for FY28; work progressing irrespective of current equipment issues.
  • Haryana CAPEX for FY27 is limited to infrastructure and related activities due to delayed IOC styrene monomer plant; major spending on PS and EPS pending clearer commissioning timeline.

2 more points from Supreme Petrochem Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Chemicals & Petrochemicals

Ranked on what management guided this quarter

Guidance-ranked
2Shiv Texchem
Rev 1Mar 2
3
Rev 1Mar 3
4
Rev 1Mar 3
5
Rev 1Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Supreme Petrochem Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Supreme Petrochem Ltd said on order book & pipeline — free account, 30 seconds.

Supreme Petrochem Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Supreme Petrochem Ltd Q4 FY26 results — key figures

Supreme Petrochem Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue1,5871,539+3.1%1,265+25.5%
Operating profit (EBITDA)253145+74.5%69+266.7%
Operating margin16%9%+7 pp5%+11 pp
Profit before tax229143+60.1%40+472.5%
Net profit (PAT)168107+57%30+460%
EPS (₹)8.945.68+57.4%1.60+458.7%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.0K Cr, net profit ₹95 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Chemicals & Petrochemicals this season

  • Indian Phosphate (Q4 FY26)

    H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In

  • Paragon Fine (Q4 FY26)

    Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p

  • IVP (Q4 FY26)

    Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector

  • Vishnu Chemicals (Q4 FY26)

    Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Supreme Petrochem Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Supreme Petrochem Ltd Q4 FY26 results?

The company expects an 8% to 10% volume growth in FY27, contingent on global market normalization by June-July 2026. The company anticipates volume growth of 8-10% for the year if global conditions, including war impacts, normalize by June-July 2026.

What is Supreme Petrochem Ltd share price analysis?

Supreme Petrochem Ltd currently shows a neutral. The stock trades at a P/E of 27.1 with a market cap of ₹13,276 Cr. Investors should review the full earnings analysis for detailed insights.

Is Supreme Petrochem Ltd planning capital expenditure?

EPS Phase-II expansion at Nagothane commissioned in April 2026, increasing capacity from 85,000 to 115,000 tons per annum.

Keep Supreme Petrochem Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.